A detailed history of Mpm Asset Management LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Mpm Asset Management LLC holds 682,376 shares of DYN stock, worth $9.7 Million. This represents 16.87% of its overall portfolio holdings.

Number of Shares
682,376
Previous 1,561,496 56.3%
Holding current value
$9.7 Million
Previous $55.1 Million 55.52%
% of portfolio
16.87%
Previous 30.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$31.94 - $47.04 $28.1 Million - $41.4 Million
-879,120 Reduced 56.3%
682,376 $24.5 Million
Q2 2024

Aug 14, 2024

SELL
$23.65 - $35.63 $44.7 Million - $67.3 Million
-1,889,807 Reduced 54.76%
1,561,496 $55.1 Million
Q1 2024

May 15, 2024

SELL
$13.06 - $29.18 $19.6 Million - $43.8 Million
-1,500,000 Reduced 30.3%
3,451,303 $98 Million
Q3 2020

Nov 13, 2020

BUY
$20.0 - $23.9 $99 Million - $118 Million
4,951,303 New
4,951,303 $100 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $736M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Mpm Asset Management LLC Portfolio

Follow Mpm Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mpm Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mpm Asset Management LLC with notifications on news.